What's New

003 TENS and PENS-PNT

008 Laboratory Testing for HIV Tropism

016 Homocysteine Testing

039 Neuropsychological Testing

042 Wearable Cardioverter Defibrillators

046 Total Hip Resurfacing

048 Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy

050 Corneal Endothelial Microscopy

053 Ophthalmologic Techniques to Evaluate the Retinal Nerve Fiber Layer

054 Corneal Pachymetry

055 Assays of Genetic Expression in Tumor Tissue

057 Pregabalin (Lyrica)

058 Bisphosphonate, Oral

060 Outpatient Cardiac Rehabilitation

061 Bisphosphonates, Infusion-Injection

062 Natalizumab (Tysabri)

063 Oncology, Oral

065 Screening for Diabetic Retinopathy

067 Genetic Testing for Tamoxifen Treatment

069 Esophageal pH Monitoring

070 Implantable Cardioverter Defibrillator

082 Genetic Testing for Congenital Long QT Syndrome

083 Spinal, Vagal, Deep Brain, Cerebellar Stimulation

084 Anterior Eye Segment Optical Imaging

085 Image Guided Radiation Therapy for Prostate Cancer

088 Preimplantation Genetic Testing

090 Intensity Modulated Radiation Therapy of the Prostate

091 Endobronchial Brachytherapy

093 Lubiprostone (Amitiza)

095 Iontophoresis

096 Pharmacogenomic and Metabolite Markers for Patients Treated with Azathioprine (6-MP)

097 Bone Morphogenetic Protein

098 Endovascular Grafts for Abdominal Aortic Aneurysms (AAA)

100 Inhaled Nitric Oxide as a Treatment of Hypoxic Respiratory Failure in Neonates

101 Biventricular Pacemakers for the Treatment of Congestive Heart Failure

103 Interleukin-2 (IL-2)

104 KRAS Mutation Analysis in Metastatic Colorectal Cancer

105 Percutaneous Vertebroplasty and Percutaneous Kyphoplasty

107 Continuous or Intermittent Monitoring of Glucose in Interstitial Fluid

108 Medicare Advantage Prescription Drug Prior Authorization Criteria

109 Medicare Advantage Prescription Drug Step Therapy Criteria

110 Meniscal Allograft Transplantation

111 Osteochondral Allograft Transplantation, Osteochondral Autograft Transplantation

112 Cinryze (C1 Inhibitor (Human))

113 Fentanyl, oral-transmucosal

114 Epidermal Growth Factor Receptor (EGFR) Inhibitors

115 Banzel (rufinamide)

119 Dopamine Agonists, non-ergot derived

120 Oscillatory Devices for the Treatment of Cystic Fibrosis and Other Respiratory Disorders

121 Closure Devices for Patent Foramen Ovale and Atrial Septal Defects

122 Chelation Therapy

130 Minimally Invasive Surgery for Snoring, Obstructive Sleep Apnea/Upper Airway Resistance Syndrome

133 Microprocessor Controlled Prostheses for the Lower Limb

135 Immunochemical Fecal Occult Blood Testing

136 Outpatient Pulmonary Rehabilitation

137 Magnetoencephalography-Magnetic Source Imaging

138 Serological Diagnosis of Celiac Disease

139 Magnetic Resonance Imaging to Monitor Integrity of Gel Filled Breast Implants

140 Radiofrequency Facet Joint Denervation

141 Radiofrequency Ablation of the Pulmonary Vein for Treatment of Atrial Fibrillation

142 Anti-CCP testing for rheumatoid arthritis

143 Hematopoietic Stem Cell Transplantation for Non-Hodgkin Lymphomas

150 Hematopoietic Stem cell Transplantation for Acute Myeloid Leukemia

166 Outpatient Medical Prior Authorization Form

277 Stereotactic Radiosurgery & Stereotactic Body Radiation Therapy

363 Psychological Testing

812 Managed Care, Indemnity and PPO Guidelines Processing Information

999 Policy Updates

Blue Cross and Blue Shield of Massachusetts is an Independent Licensee of the Blue Cross and Blue Shield Association.
® Registered Marks of the Blue Cross and Blue Shield Association.
© 2009 Blue Cross and Blue Shield of Massachusetts, Inc., and Blue Cross Blue Shield of Massachusetts HMO Blue, Inc.
Landmark Center, 401 Park Drive, Boston, MA 02215-3326 | 800-262-BLUE | TDD# 800-522-1254